ZA851293B - Condensed seven-membered compounds,their production and use - Google Patents

Condensed seven-membered compounds,their production and use

Info

Publication number
ZA851293B
ZA851293B ZA851293A ZA851293A ZA851293B ZA 851293 B ZA851293 B ZA 851293B ZA 851293 A ZA851293 A ZA 851293A ZA 851293 A ZA851293 A ZA 851293A ZA 851293 B ZA851293 B ZA 851293B
Authority
ZA
South Africa
Prior art keywords
condensed
production
membered compounds
membered
compounds
Prior art date
Application number
ZA851293A
Other languages
English (en)
Inventor
Hirosada Sugihara
Kohei Nishikawa
Katsumi Ito
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of ZA851293B publication Critical patent/ZA851293B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
ZA851293A 1984-03-24 1985-02-20 Condensed seven-membered compounds,their production and use ZA851293B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP1984/000119 WO1985004402A1 (en) 1984-03-24 1984-03-24 Fused 7-membered ring compounds and process for their preparation

Publications (1)

Publication Number Publication Date
ZA851293B true ZA851293B (en) 1986-10-29

Family

ID=13818277

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA851293A ZA851293B (en) 1984-03-24 1985-02-20 Condensed seven-membered compounds,their production and use

Country Status (5)

Country Link
JP (1) JPS60231668A (enrdf_load_stackoverflow)
HU (1) HUT38631A (enrdf_load_stackoverflow)
PH (1) PH24015A (enrdf_load_stackoverflow)
WO (1) WO1985004402A1 (enrdf_load_stackoverflow)
ZA (1) ZA851293B (enrdf_load_stackoverflow)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2607004B1 (fr) * 1986-11-20 1990-06-01 Synthelabo Compositions pharmaceutiques contenant du diltiazem et un inhibiteur de l'enzyme de conversion de l'angiotensine
JPH0657707B2 (ja) * 1987-05-25 1994-08-03 吉富製薬株式会社 ピペリジン化合物
DE4322109C2 (de) * 1993-07-02 2001-02-22 Franz Durst Brenner für ein Gas/Luft-Gemisch
FR2751981B1 (fr) * 1996-08-02 1998-09-11 Rhone Poulenc Chimie Fluide comprenant des microfibrilles de cellulose et son application pour l'exploitation de gisementss petroliers
JP2002241368A (ja) * 1997-02-18 2002-08-28 Shionogi & Co Ltd 新規ベンゾラクタム誘導体およびそれを含有する医薬組成物
WO1998041510A1 (fr) * 1997-03-14 1998-09-24 Shionogi & Co., Ltd. Nouveaux derives du benzolactame et compositions medicamenteuses les contenant

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58116477A (ja) * 1981-06-05 1983-07-11 メルク・エンド・カムパニ−・インコ−ポレ−テツド 抗高血圧剤としてのパ−ヒドロ−１，４−チアゼピン−５−オンおよびパ−ヒドロ−１，４−チアゾシン−５−オン誘導体
US4460579A (en) * 1983-02-28 1984-07-17 E. R. Squibb & Sons, Inc. Thiazine and thiazepine containing compounds

Also Published As

Publication number Publication date
JPS60231668A (ja) 1985-11-18
HUT38631A (en) 1986-06-30
PH24015A (en) 1990-02-09
JPH0566389B2 (enrdf_load_stackoverflow) 1993-09-21
WO1985004402A1 (en) 1985-10-10

Similar Documents

Publication Publication Date Title
DE3574379D1 (en) Tetrahydrophtalimides, and their production and use
DE3563627D1 (en) Triazolopyridazines, and their production and use
ZA859018B (en) Polymerizatin catalyst,production and use
CS78585A2 (en) Zpusob vyroby 1,3 disubstituovanych 2 oxindolu
EP0203271A3 (en) Antibacterial compounds, their production and use
DE3568435D1 (en) 2-acetoacetylglycerol derivatives, their production and use
ZA851293B (en) Condensed seven-membered compounds,their production and use
ZA842926B (en) Condensed,seven-membered ring compounds and their use
GB2162175B (en) 1,8-diacyloxy-10-acylanthrones
DE3460445D1 (en) Pyridotriazolium compounds, and their production and use
ZA85575B (en) 1,3,2-dioxaborinanes
IL74004A0 (en) Condensed seven-membered ring compounds and their production and use
ZA851236B (en) 2-arylimidazo 4,5-cpyridines
GB2156353B (en) 6,6-ethylenedioxy-22r-hydroxy-2r,3s-isopropylidenedioxy-5a-cholest-23-yne
CS320285A2 (en) Zpusob vyroby n,3 disubstituovanych 2 oxindol 1 karboxamidu
CS219684A1 (en) Sposob pripravy 1 2,6 dimetylfenoxy 2 propylaminu
ZA861566B (en) Antibacterial compounds,their production and use
PT79057A (en) Condensed seven-membered ring compounds and their production and use
EP0262589A3 (en) Triazole compounds, and their production
EP0170822A3 (en) 2,3-dihydrobenzo-4-oxa-thiine
ZA857235B (en) Triazolopyridazines,and their production and use
EP0169807A3 (en) Polyamide, process for its fabrication and its use
CS998884A1 (en) Derivaty l,4 dihydropyridinu
IL75289A0 (en) 2,2-dimethyl-3-formylcyclopropanes and their production
CS285084A1 (en) Vozidlo s diferencovanym pohonem hnacich kolies, regulovanym od riadiaceho mechanizmu